PPARα was shown to be a direct target of β-catenin (CTNNB1) in human HCC, and PPARα expression was higher in CTNNB1-mutated human HCC than in non-mutated tumors. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.